Study pinpoints ideal sedative dose for kids' scope procedures
NCT ID NCT06121609
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aimed to find the most effective dose of remimazolam, a sedative, for children aged 0-12 undergoing painless bidirectional endoscopy. Researchers tested different doses in 165 children to see which level safely and reliably produced adequate sedation. The goal is to improve sedation practices for pediatric endoscopic procedures.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BIDIRECTIONAL ENDOSCOPY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Tongji Hospital
Wuhan, Hubei, 430000, China